Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer

Researchers have developed and validated a liquid biopsy assay that can predict response to neoadjuvant therapy in patients with esophageal squamous-cell carcinoma, which may lead to more personalized treatment decisions.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news